[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris
O
O
Virologie et pathologie humaine, CNRS FRE 3011, université de Lyon, université Lyon-1, 7, rue Guillaume-Paradin, 69372 Lyon cedex 08, France.
Escuret
V
V
Bouscambert-Duchamp
M
M
Lina
B
B
Morfin
F
F
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D004311:Double-Blind Method; D024882:Drug Resistance, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D009980:Influenza A virus / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D008297:Male; D008958:Models, Molecular; D015394:Molecular Structure; D020125:Mutation, Missense; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics; D053139:Oseltamivir / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D017354:Point Mutation; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000821:virology; D011487:Protein Conformation; D014764:Viral Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics; D053243:Zanamivir / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
D000998:Antiviral Agents; D014764:Viral Proteins; D053139:Oseltamivir; C487630:NA protein, influenza A virus; D009439:Neuraminidase; D053243:Zanamivir
Intérêts des inhibiteurs de la neuraminidase dans la prise en charge des infections dues aux virus influenza.